We are live on ! Find out more
ACGN

Aceragen Inc

Delisted

ACGN was delisted on the 21st of August, 2023.

56 hedge funds and large institutions have $12.8M invested in Aceragen Inc in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

6% more funds holding

Funds holding: 5356 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

64% less capital invested

Capital invested by funds: $35M → $12.8M (-$22.2M)

65% less call options, than puts

Call options by funds: $722K | Put options by funds: $2.08M

Holders
56
Holders Change
+3
Holders Change %
+5.66%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
20
Reduced
11
Closed
13
Calls
$722K
Puts
$2.08M
Net Calls
-$1.36M
Net Calls Change
-$1.41M
Name Holding Trade Value Shares
Change
Change in
Stake
SM
26
SG3 Management
Puerto Rico
$45K +$153K +2,043 New
WSFS
27
Wilmington Savings Fund Society
Delaware
$44K +$19K +254 +15%
ASN
28
Advisory Services Network
Georgia
$44K +$150K +2,002 New
ECM
29
ExodusPoint Capital Management
New York
$38K -$18.7K -250 -13%
State Street
30
State Street
Massachusetts
$27K +$8.84K +118 +11%
CIBC Private Wealth Group
31
CIBC Private Wealth Group
Georgia
$27K +$90.4K +1,207 New
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$26K
Charles Schwab
33
Charles Schwab
California
$24K +$81.3K +1,086 New
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$21K
Bank of New York Mellon
35
Bank of New York Mellon
New York
$19K -$9.29K -124 -13%
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
$18K -$247K -3,298 -80%
Assenagon Asset Management
37
Assenagon Asset Management
Luxembourg
$18K -$7.42K -99 -11%
Barclays
38
Barclays
United Kingdom
$16K +$54.7K +730 New
RWA
39
Ropes Wealth Advisors
Massachusetts
$11K -$2.4K -32 -5%
TRCT
40
Tower Research Capital (TRC)
New York
$11K +$6.29K +84 +21%
PNC Financial Services Group
41
PNC Financial Services Group
Pennsylvania
$4K -$13.3K -177 -48%
UBS Group
42
UBS Group
Switzerland
$4K -$11.5K -153 -44%
Bank of America
43
Bank of America
North Carolina
$3K -$212K -2,824 -96%
Northwestern Mutual Wealth Management
44
Northwestern Mutual Wealth Management
Wisconsin
$3K
JG
45
Jefferies Group
New York
$2.98K +$10.1K +135 New
Federated Hermes
46
Federated Hermes
Pennsylvania
$2K +$4.2K +56 +127%
Osaic Holdings
47
Osaic Holdings
Arizona
$1K
PAM
48
Panagora Asset Management
Massachusetts
$1K
CAPTRUST Financial Advisors
49
CAPTRUST Financial Advisors
North Carolina
$1K +$3.6K +48 New
MAM
50
Meeder Asset Management
Ohio
$1K +$3.67K +49 New

ACGN Hedge Fund Activity: Q1 2021 in Review

56 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Aceragen Inc (ACGN) for Q1 2021, worth a combined $12.8M — down 64% from $35M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ACGN positions and 13 closed out — a net gain of 4 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $7.53M. The largest seller was Baker Bros. Advisors, cutting an estimated $11.3M.

  • 56 institutional investors held Aceragen Inc (ACGN) as of Q1 2021, up from 53 in Q4 2020.
  • Funds reported $12.8M of Aceragen Inc stock for Q1 2021, down 64% quarter-over-quarter.
  • 17 funds opened new Aceragen Inc positions in Q1 2021 and 13 closed out, a net change of +4 holders.
  • The largest Aceragen Inc buyer in Q1 2021 was Anson Funds Management, an estimated $7.53M added.
  • The largest Aceragen Inc seller in Q1 2021 was Baker Bros. Advisors, an estimated $11.3M sold.

Based on aggregated 13F filings for Q1 2021.